Literature DB >> 26195802

Spontaneous retrotransposon insertion into TNF 3'UTR causes heart valve disease and chronic polyarthritis.

Derek Lacey1, Peter Hickey1, Benedicta D Arhatari2, Lorraine A O'Reilly1, Leona Rohrbeck1, Helen Kiriazis3, Xiao-Jun Du3, Philippe Bouillet4.   

Abstract

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are chronic inflammatory diseases that together affect 2-3% of the population. RA and AS predominantly involve joints, but heart disease is also a common feature in RA and AS patients. Here we have studied a new spontaneous mutation that causes severe polyarthritis in bone phenotype spontaneous mutation 1 (BPSM1) mice. In addition to joint destruction, mutant mice also develop aortic root aneurism and aorto-mitral valve disease that can be fatal depending on the genetic background. The cause of the disease is the spontaneous insertion of a retrotransposon into the 3' untranslated region (3'UTR) of the tumor necrosis factor (TNF), which triggers its strong overexpression in myeloid cells. We found that several members of a family of RNA-binding, CCCH-containing zinc-finger proteins control TNF expression through its 3'UTR, and we identified a previously unidentified regulatory element in the UTR. The disease in BPSM1 mice is independent of the adaptive immune system and does not appear to involve inflammatory cytokines other than TNF. To our knowledge, this is the first animal model showing both polyarthritis and heart disease as a direct result of TNF deregulation. These results emphasize the therapeutic potential of anti-TNF drugs for the treatment of heart valve disease and identify potential therapeutic targets to control TNF expression and inflammation.

Entities:  

Keywords:  CCCH ZFP; gene regulation; heart valve disease; mRNA stability; rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26195802      PMCID: PMC4534232          DOI: 10.1073/pnas.1508399112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

2.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.

Authors:  Kohki Kawane; Mayumi Ohtani; Keiko Miwa; Takuji Kizawa; Yoshiyuki Kanbara; Yoshichika Yoshioka; Hideki Yoshikawa; Shigekazu Nagata
Journal:  Nature       Date:  2006-10-26       Impact factor: 49.962

3.  Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice.

Authors:  Y Niki; H Yamada; S Seki; T Kikuchi; H Takaishi; Y Toyama; K Fujikawa; N Tada
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

6.  Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs.

Authors:  Kathrin Leppek; Johanna Schott; Sonja Reitter; Fabian Poetz; Ming C Hammond; Georg Stoecklin
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

7.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis.

Authors:  Geert van Loo; Mohamed Lamkanfi; Lieselotte Vande Walle; Nina Van Opdenbosch; Peggy Jacques; Amelie Fossoul; Eveline Verheugen; Peter Vogel; Rudi Beyaert; Dirk Elewaut; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2014-06-29       Impact factor: 49.962

10.  Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene.

Authors:  M Malissen; A Gillet; L Ardouin; G Bouvier; J Trucy; P Ferrier; E Vivier; B Malissen
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  11 in total

1.  The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome.

Authors:  Moritz Haneklaus; John D O'Neil; Andrew R Clark; Seth L Masters; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2017-03-16       Impact factor: 5.157

2.  Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

Authors:  Maria Sakkou; Panagiotis Chouvardas; Lydia Ntari; Alejandro Prados; Kristin Moreth; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Maria C Denis; Niki Karagianni; George Kollias
Journal:  JCI Insight       Date:  2018-04-05

3.  Natural variation of the cardiac transcriptome in humans.

Authors:  Tatiana Domitrovic; Mariana H Moreira; Rodolfo L Carneiro; Marcelo Ribeiro-Alves; Fernando L Palhano
Journal:  RNA Biol       Date:  2020-12-11       Impact factor: 4.652

4.  Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Authors:  Zikou Liu; Laura F Dagley; Kristy Shield-Artin; Samuel N Young; Aleksandra Bankovacki; Xiangyi Wang; Michelle Tang; Jason Howitt; Che A Stafford; Ueli Nachbur; Cheree Fitzgibbon; Sarah E Garnish; Andrew I Webb; David Komander; James M Murphy; Joanne M Hildebrand; John Silke
Journal:  EMBO J       Date:  2021-10-26       Impact factor: 11.598

5.  TNF-induced chronic inflammation does not affect tumorigenesis driven by p53 loss.

Authors:  Derek Lacey; Andreas Strasser; Philippe Bouillet
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

Review 6.  Cardiac phenotype in mouse models of systemic autoimmunity.

Authors:  Chandan Sanghera; Lok Man Wong; Mona Panahi; Amalia Sintou; Muneer Hasham; Susanne Sattler
Journal:  Dis Model Mech       Date:  2019-03-08       Impact factor: 5.758

7.  Artificial Intelligence Models Reveal Sex-Specific Gene Expression in Aortic Valve Calcification.

Authors:  Philip Sarajlic; Oscar Plunde; Anders Franco-Cereceda; Magnus Bäck
Journal:  JACC Basic Transl Sci       Date:  2021-04-14

8.  miR-27a protects human mitral valve interstitial cell from TNF-α-induced inflammatory injury via up-regulation of NELL-1.

Authors:  Honglei Chen; Zhixu Zhang; Li Zhang; Junzhi Wang; Minghui Zhang; Bin Zhu
Journal:  Braz J Med Biol Res       Date:  2018-04-19       Impact factor: 2.590

9.  Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasia.

Authors:  Cyril Seillet; Elysa Carr; Derek Lacey; Michael D Stutz; Marc Pellegrini; Lachlan Whitehead; Joel Rimes; Edwin D Hawkins; Ben Roediger; Gabrielle T Belz; Philippe Bouillet
Journal:  Immunol Cell Biol       Date:  2018-09-08       Impact factor: 5.126

10.  Premature Onset Aortic Stenosis in Systemic Sclerosis: A Report of a Series of Cases.

Authors:  Ayaka Machida; Takashi Funaki; Koji Nishida; Ryu-Ichiro Imai; Yoko Nakaoka; Shu-Ichi Seki; Yu-Ichi Baba; Toru Kubo; Naohito Yamasaki; Hiroaki Kitaoka; Sho-Ichi Kubokawa; Hiroshi Sakaeda; Kazuya Kawai; Naohisa Hamashige; Yoshinori Doi
Journal:  Intern Med       Date:  2020-08-12       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.